These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5778893)

  • 1. [Influence of fibrinolytic activation on the determination of factor XIII].
    Pola P; Bianco S; Bizzi B
    Policlinico Prat; 1969 Feb; 76(8):233-6. PubMed ID: 5778893
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of factor XIII deficiency with cryoprecipitate.
    Amris CJ; Hilden M
    Thromb Diath Haemorrh; 1968 Dec; 20(3):528-33. PubMed ID: 5710469
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolytic bleeding complicated by factor 13 defect.
    Baggett RT; Hampton JW; Bird RM
    Arch Intern Med; 1968 Jun; 121(6):539-44. PubMed ID: 5652406
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood-aqueous barrier changes during activation of fibrinolysis in plasma].
    Rudobielski R
    Klin Oczna; 1974 Feb; 44(2):129-33. PubMed ID: 4453093
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in the determination of blood coagulation factors].
    Fukutake K
    Rinsho Ketsueki; 1979 May; 20(5):462-75. PubMed ID: 313461
    [No Abstract]   [Full Text] [Related]  

  • 6. [Assay procedures of blood coagulation factors. Phase I].
    Fujimaki M; Yasui T
    Rinsho Byori; 1969; 16():Suppl 16:75-84. PubMed ID: 5391588
    [No Abstract]   [Full Text] [Related]  

  • 7. The monoiodoacetate (MIA) tolerance test, a new quantitative method for the fibrin stabilizing factor (factor 13) assay.
    Sigg P
    Thromb Diath Haemorrh; 1966 Jan; 15(1):238-51. PubMed ID: 5919804
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heparin complex formation with plasma fibrin-stabilizing factor in vitro].
    Ul'ianov AM; Kudriashov BA; Liapina LA
    Biokhimiia; 1973; 38(6):1281-7. PubMed ID: 4802010
    [No Abstract]   [Full Text] [Related]  

  • 9. Differentiation between plasminogen activators by means of epsilon-aminocaproic acid.
    Kok P; Astrup T
    Thromb Diath Haemorrh; 1972 Feb; 27(1):77-87. PubMed ID: 4260740
    [No Abstract]   [Full Text] [Related]  

  • 10. [A quantitative determination of factor 13 with anti-factor 13 serum].
    Bohn H; Haupt H
    Thromb Diath Haemorrh; 1968 Jul; 19(3):309-15. PubMed ID: 4974323
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor XIII in human plasma and platelets.
    McDonagh J; McDonagh RP; Delâge JM; Wagner RH
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
    [No Abstract]   [Full Text] [Related]  

  • 13. [Approach of hematology. Abnormal findings of coagulation and fibrinolytic factors in DIC].
    Ikematsu S; Kato M; Kuroso K
    Rinsho Byori; 1984 Aug; 32(8):862-8. PubMed ID: 6502985
    [No Abstract]   [Full Text] [Related]  

  • 14. [The coagulation and fibrinolytic properties of rabbit erythrocytes].
    Potekhin KG; Nikitin IuP; Fedenkov VI
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1972; 3(99):47-51. PubMed ID: 4265540
    [No Abstract]   [Full Text] [Related]  

  • 15. Action of epsilon-aminocaproic acid and of parotid inhibitor on the fibrinolysis activation due to nicotinic acid derivatives and to heparin-like substances.
    Gibelli A; Turazza G; Giarola P; De Nicola P
    Farmaco Sci; 1966 Apr; 21(4):301-9. PubMed ID: 4160699
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolytic activity in lesions of hereditary hemorrhagic telangiectasia.
    Kwaan HC; Silverman S
    Arch Dermatol; 1973 Apr; 107(4):571-3. PubMed ID: 4697687
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzymatic method for the quantitative determination of factor. XIII. Application to a familial deficiency.
    Janssen CL; Masure R
    Pathol Eur; 1970; 5(3):315-30. PubMed ID: 5477027
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood coagulation factors in ulcerative colitis with special reference to factor XIII].
    Suzuki R
    Nihon Shokakibyo Gakkai Zasshi; 1987 Feb; 84(2):307. PubMed ID: 3586380
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemorrhagic diathesis caused by a deficiency of the fibrin-stabilizing factor (factor 13)].
    Lechler E; Köhler J
    Verh Dtsch Ges Inn Med; 1968; 74():144-7. PubMed ID: 5714300
    [No Abstract]   [Full Text] [Related]  

  • 20. [The blood coagulation system and cortisol metabolism in Itsenko-Cushing disease].
    Vasiukova EA; Pisarskaia IV; Skvortsova RI
    Ter Arkh; 1969 Jul; 41(7):85-8. PubMed ID: 5374416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.